Investment in India's growing life and analytical sciences market, seen as a key growth market for biopharma, environmental, chemical and genetic screening businesses
PerkinElmer, a provider of drug discovery, life science research, and analytical solutions, and Labindia Instruments, a lab service and marketing organisation, have jointly announced the launch of PerkinElmer India, a direct sales, service and marketing operation targeting India's thriving life science and analytical instrumentation markets.
The partnership provides a strong growth opportunity for PerkinElmer and underscores the company's commitment to customers in the region.
PerkinElmer will hold a majority interest in the joint venture, which will be headquartered in Thane, India, with demo facilities and sales offices in Mumbai, Thane, New Delhi, Chennai, Baroda, Pune, Hyderabad, Lucknow, Kolkatta and Bangalore.
PerkinElmer India will employ 180 people dedicated to direct sales, service, technical support and administration.
"India represents a key growth market for a number of PerkinElmer businesses, including biopharma, environmental and chemical, and genetic screening," said Peter Coggins, president, PerkinElmer Life and Analytical Sciences.
"We are pleased to be working with Labindia to bring the full range of our life and analytical sciences product and service portfolio to India's rapidly expanding community of scientists and researchers". "This joint venture is the natural extension of a relationship that has been successful for more than 23 years," said Shriram Bhalerao, managing director of Labindia.
"PerkinElmer India will harness the combined strengths of both companies to drive growth opportunities: Labindia's superior knowledge, service and support of the India market, and PerkinElmer's operational excellence and technology expertise."
